Rep. Andy Biggs

Maddy summaryThis bill establishes a $3.49 billion spending cap for the National Heart, Lung, and Blood Institute (NHLBI) within the National Institutes of Health for fiscal year 2024. It directly limits the Department of Health and Human Services' available funding for NHLBI to this specific amount, preventing increases above the threshold. The provision applies exclusively to NHLBI's appropriations under the NIH, with no broader policy changes or additional mechanisms described.

Maddy summaryHR 1995 imposes a spending cap of $314.68 million on the National Institute on Minority Health and Health Disparities (NIMHD) within the National Institutes of Health for fiscal year 2024. This bill directly affects the NIMHD by restricting its available funding to this specific amount, regardless of other authorizations. The key provision is a hard limit on federal funds for the institute’s operations and programs during FY2024. It does not alter the institute’s mission or create new policies, only sets a maximum funding level for that fiscal year.

Maddy summaryHR 1994 sets a funding cap of $146,473,000 for the National Center for Complementary and Integrative Health (NCCIH) within the National Institutes of Health for fiscal year 2024. This bill directly affects the NCCIH by limiting the total funds it can access during FY2024, preventing it from exceeding this specific amount. The provision applies to funds authorized for the NCCIH and overrides any other law that might allow higher spending. It does not change the center's research focus or programs, only the maximum budget available. This is a procedural funding limitation, not a policy change to health care or research priorities.

Maddy summaryThis bill sets a spending limit for the National Cancer Institute within the Department of Health and Human Services for fiscal year 2024. It caps the total funds available to the institute at $5,743,892,000, preventing any amount above this figure from being used for that fiscal year. The provision directly affects the institute's ability to allocate resources for cancer research and related programs during the specified period. By establishing this financial ceiling, the legislation ensures that funding for the National Cancer Institute remains within a predetermined budgetary constraint.

Maddy summaryThis bill (HR 1968) sets a specific funding cap of $648,559,000 for the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control program during fiscal year 2024. It directly affects the CDC's ability to allocate funds for programs focused on preventing injuries, such as those related to motor vehicles, falls, or violence. The key provision is a legal restriction preventing the use of more than the specified amount for this particular CDC program in FY2024. This is a procedural spending limitation, not a change to public health policy.

Maddy summaryHR 1967 sets a funding limit of $192.35 million for the Centers for Disease Control and Prevention's (CDC) Environmental Health division during fiscal year 2024. This bill directly affects the CDC's ability to allocate resources to environmental health programs by restricting available funds to this specific amount. The provision applies to all funds authorized for this division in FY2024, overriding other funding provisions. It is a procedural budgetary measure with no policy changes beyond the spending cap.

Maddy summaryThis bill sets a spending limit of $163,570,000 for the Centers for Disease Control and Prevention's (CDC) "Wide Activities and Program Support" program during fiscal year 2024. It restricts the CDC from using more than this specific amount from available funds for these activities. The limitation directly affects the CDC's budget authority for this particular program under the Department of Health and Human Services.

Maddy summaryThis bill limits funding for the Substance Abuse Prevention program within the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Department of Health and Human Services to $205,469,000 for fiscal year 2024. It directly affects SAMHSA's ability to allocate resources to state and community programs focused on preventing substance abuse. The key provision is a strict spending cap that prevents the program from using more than this specified amount, regardless of other funding authorizations. This is a procedural budgetary measure, not a new policy, and does not alter program eligibility or services.

Maddy summaryHR 1980 sets a funding cap of $5.52 billion for the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly limits the amount of federal funds the NIAID can spend on its programs during that fiscal year. The key provision is a strict dollar limit that prevents the agency from using more than this specified amount, regardless of other funding authorizations. This affects NIAID's budget planning and spending for research and operations in 2024.

Maddy summaryHR 1992 sets a spending cap of $575,579,000 for the National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly limits the available funds for NHGRI's research and operations during 2024, preventing the agency from exceeding this specific dollar amount. The restriction applies to all appropriations authorized for NHGRI under the Department of Health and Human Services budget for that fiscal year.